Advertisement
AMS vs HCA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMS is a Hold and HCA is a Buy.
AMS sees its Stochastic Oscillator recovers from oversold territory
On October 22, 2026, the Stochastic Oscillator for AMS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In 49 of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMS's RSI Oscillator exited the oversold zone, 5 of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for AMS just turned positive on October 27, 2026. Looking at past instances where AMS's MACD turned positive, the stock continued to rise in 32 of 45 cases over the following month. The odds of a continued upward trend are 71%.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 127 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMS as a result. In 89 of 138 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
AMS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMS entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.365) is normal, around the industry mean (204.120). P/E Ratio (-4.885) is within average values for comparable stocks, (19.084). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.150) settles around the average of (0.091) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
HCA in +6.25% Uptrend, growing for three consecutive days on October 29, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HCA advanced for three days, in 247 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on HCA as a result. In 60 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for HCA just turned positive on October 30, 2026. Looking at past instances where HCA's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 206 of 322 cases where HCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Bearish Trend Analysis
The 10-day RSI Indicator for HCA moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In 29 of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 66 cases where HCA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
HCA broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. HCA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.424) is normal, around the industry mean (204.120). P/E Ratio (15.658) is within average values for comparable stocks, (19.084). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (2.498). Dividend Yield (0.007) settles around the average of (0.091) among similar stocks. P/S Ratio (1.264) is also within normal values, averaging (2.688).
AMS | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 34 | |
SMR RATING 1..100 | 93 | 45 | |
PRICE GROWTH RATING 1..100 | 76 | 32 | |
P/E GROWTH RATING 1..100 | 27 | 61 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (4) in the Medical Or Nursing Services industry is somewhat better than the same rating for HCA (63) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew somewhat faster than HCA’s over the last 12 months.
HCA's Profit vs Risk Rating (34) in the Hospital Or Nursing Management industry is significantly better than the same rating for AMS (100) in the Medical Or Nursing Services industry. This means that HCA’s stock grew significantly faster than AMS’s over the last 12 months.
HCA's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMS (93) in the Medical Or Nursing Services industry. This means that HCA’s stock grew somewhat faster than AMS’s over the last 12 months.
HCA's Price Growth Rating (32) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMS (76) in the Medical Or Nursing Services industry. This means that HCA’s stock grew somewhat faster than AMS’s over the last 12 months.
AMS's P/E Growth Rating (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for HCA (61) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew somewhat faster than HCA’s over the last 12 months.
| AMS | HCA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 63% | 3 days ago 59% |
| Stochastic ODDS (%) | 3 days ago 74% | 3 days ago 56% |
| Momentum ODDS (%) | 3 days ago 64% | 3 days ago 68% |
| MACD ODDS (%) | 3 days ago 71% | 3 days ago 70% |
| TrendWeek ODDS (%) | 3 days ago 67% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 68% |
| Advances ODDS (%) | 5 days ago 63% | 4 days ago 71% |
| Declines ODDS (%) | 13 days ago 65% | 6 days ago 62% |
| BollingerBands ODDS (%) | 3 days ago 79% | 3 days ago 53% |
| Aroon ODDS (%) | 3 days ago 68% | 3 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while HCA’s FA Score has 1 green FA rating(s).
- AMS’s FA Score: 2 green, 3 red.
- HCA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).
- AMS’s TA Score: 4 bullish, 4 bearish.
- HCA’s TA Score: 4 bullish, 4 bearish.
Price Growth
AMS (@Hospital/Nursing Management) experienced а +0.79% price change this week, while HCA (@Hospital/Nursing Management) price change was +0.89% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.92%. For the same industry, the average monthly price growth was +4.04%, and the average quarterly price growth was +19.38%.
Reported Earning Dates
AMS is expected to report earnings on Nov 12, 2026.
HCA is expected to report earnings on Feb 02, 2027.
Industries' Descriptions
@Hospital/Nursing Management (+0.92% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
AMS and
Correlation & Price change
A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.
| Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
|---|---|---|---|---|
| AMS | 100% | +0.79% | ||
| BKD - AMS | 23% Poorly correlated | +1.17% | ||
| PNTG - AMS | 21% Poorly correlated | -1.93% | ||
| ADUS - AMS | 15% Poorly correlated | +0.97% | ||
| HCA - AMS | 14% Poorly correlated | -1.02% | ||
| THC - AMS | 11% Poorly correlated | +0.99% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To HCA | 1D Price Change % | ||
|---|---|---|---|---|
| HCA | 100% | -1.02% | ||
| UHS - HCA | 66% Closely correlated | -0.32% | ||
| THC - HCA | 62% Loosely correlated | +0.99% | ||
| ENSG - HCA | 39% Loosely correlated | -2.58% | ||
| CON - HCA | 33% Loosely correlated | -2.11% | ||
| SGRY - HCA | 32% Poorly correlated | N/A | ||
More | ||||